NASALLY ADMINISTRABLE, BIOAVAILABLE PHARMACEUTICAL COMPOSITION OF LORATADINE
摘要
The present invention relates to nasally administrable, bioavailable pharmaceutical compositions of loratadine for the treatment of allergic rhinitis and processes for their preparation. These formulations include a solid dispersion of loratadine with a carrier in an aqueous vehicle and provide the same bioavailability as an oral dosage form at reduced dose.